Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

INZIRQO 10 MG/ML ORAL SUSP

hydrochlorothiazide
$4.4490per ML
High Outlier

Strength

10 mg/mL

Manufacturer

ANI Pharmaceuticals, Inc.

NDC

70954052210

Classification

Brand

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

HYDROCHLOROTHIAZIDE

Approval Type

New Drug (NDA)

FDA Application

NDA219141

On Market Since

1/30/2025

Pharmacological Classes

Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

-0.0%

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DIURIL 250 MG/5 ML ORAL SUSP
Brand
65649031112•Salix Pharmaceuticals Inc.
$0.2787
per ML
HEMICLOR 12.5 MG TABLET
Brand
50742028530•Ingenus Pharmaceuticals LLC
$0.9571
per EA
HEMICLOR 12.5 MG TABLET
Brand
50742028590•Ingenus Pharmaceuticals LLC
$0.9571
per EA
THALITONE 15 MG TABLET
Brand
70199001730•Casper Pharma LLC
$3.5387
per EA
MICARDIS HCT 80-12.5 MG TABLET
Brand
00597004437•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4761
per EA
MICARDIS HCT 80-25 MG TABLET
Brand
00597004237•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4768
per EA
MICARDIS HCT 40-12.5 MG TABLET
Brand
00597004337•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4995
per EA
HYZAAR 50-12.5 TABLET
Brand
78206013901•Organon LLC
$5.0084
per EA
HYZAAR 50-12.5 TABLET
Brand
78206013902•Organon LLC
$5.0084
per EA
HYZAAR 100-25 TABLET
Brand
78206014101•Organon LLC
$6.8196
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy